Fidelity Select Biotechnology holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.
Fidelity Select Biotechnology Portfolio FBIOX
- NAV / 1-Day Return $28.24 / +2.58 %
- Fund Size $6.0B
- Adjusted Expense Ratio 0.620%
- Net Expense Ratio 0.620%
- Fee Level: Distribution Low
- Share Class Type No Load
- Morningstar Category Health
- Equity Style Box (Funds) Mid Growth
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 1.47%
- Turnover Ratio 45%
Morningstar’s Analysis FBIOX
Will FBIOX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 44.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
AbbVie Inc | 10.40 | 654M | Healthcare |
Krystal Biotech Inc | 10.30 | 648M | Healthcare |
Amgen Inc | 6.98 | 439M | Healthcare |
Moderna Inc | 3.49 | 220M | Healthcare |
Insmed Inc | 2.41 | 151M | Healthcare |
Revolution Medicines Inc Ordinary Shares | 2.40 | 151M | Healthcare |
argenx SE ADR | 2.32 | 146M | Healthcare |
Praxis Precision Medicines Inc Ordinary Shares | 2.29 | 144M | Healthcare |
Ascendis Pharma AS | 2.01 | 126M | Healthcare |
Natera Inc | 1.72 | 108M | Healthcare |